Depei Wu

National Clinical Research Center for Hematologic Diseases, The First Affiliated Hospital of Soochow University

Affiliated withThe First Affiliated Hospital of Soochow University

Research Area

Biography

Depei Wu has not added Biography.
If you are Depei Wu and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title	2025

Other Publications

Article	Year
High frequency of cryptic chromosomal rearrangements involving the LMO2 gene in T-cell acute lymphoblastic leukemia. Haematologica\| PubMed ID: 25682596	2015
Tislelizumab augment the efficacy of CD19/22 dual-targeted chimeric antigen receptor T cell in advanced stage relapsed or refractory B-cell non-Hodgkin lymphoma. Hematological oncology\| PubMed ID: 37776326	2024
The prognostic significance of circulating plasma cells in newly diagnosed multiple myeloma patients. Frontiers in oncology\| PubMed ID: 37799469	2023
Use of recombinant factor VIIa in uncontrolled gastrointestinal bleeding after hematopoietic stem cell transplantation among patients with thrombocytopenia. Pakistan journal of medical sciences\| PubMed ID: 26870102	2015
Impact of JAK2V617F Mutation Burden on Disease Phenotype in Chinese Patients with JAK2V617F-positive Polycythemia Vera (PV) and Essential thrombocythemia (ET). International journal of medical sciences\| PubMed ID: 26917989	2016
The Ring Finger Protein RNF6 Induces Leukemia Cell Proliferation as a Direct Target of Pre-B-cell Leukemia Homeobox 1. The Journal of biological chemistry\| PubMed ID: 26971355	2016
Cytomegalovirus induces strong antileukemic effect in acute myeloid leukemia patients following sibling HSCT without ATG-containing regimen. American journal of translational research\| PubMed ID: 27158357	2016
The Successful Complete Remission Induction by Sorafenib Monotherapy in a FLT3-D835Y-Positive Patient with Refractory Acute Monocytic Leukemia. Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion\| PubMed ID: 27408351	2016
Adoptively transferred donor IL-17-producing CD4 T cells augment, but IL-17 alleviates, acute graft-versus-host disease. Cellular & molecular immunology\| PubMed ID: 27748733	2018
Propiece IL-1α facilitates the growth of acute T-lymphocytic leukemia cells through the activation of NF-κB and SP1. Oncotarget\| PubMed ID: 28152513	2017
Multiple - fusion transcripts in a myeloproliferative neoplasm patient with t(5;17)(q32;q11). Molecular cytogenetics\| PubMed ID: 28261327	2017
Combining therapeutic antibodies using basiliximab and etanercept for severe steroid-refractory acute graft-versus-host disease: A multi-center prospective study. Oncoimmunology\| PubMed ID: 28405499	2017
Unmanipulated haploidentical stem cell transplantation in adults with acute lymphoblastic leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT. Journal of hematology & oncology\| PubMed ID: 28558762	2017
The ubiquitin-conjugating enzyme UBE2O modulates c-Maf stability and induces myeloma cell apoptosis. Journal of hematology & oncology\| PubMed ID: 28673317	2017
Clinical significance of circulating microparticles in Ph myeloproliferative neoplasms. Oncology letters\| PubMed ID: 28789461	2017
Inhibition of Acute Graft-versus-Host Disease with Retention of Graft-versus-Tumor Effects by Dimethyl Fumarate. Frontiers in immunology\| PubMed ID: 29209333	2017
High Tim-3 expression on AML blasts could enhance chemotherapy sensitivity. Oncotarget\| PubMed ID: 29254227	2017
Monitoring tyrosine kinase inhibitor therapeutic responses with a panel of metabolic biomarkers in chronic myeloid leukemia patients. Cancer science\| PubMed ID: 29316075	2018
Tracking hematopoietic precursor division ex vivo in real time. Stem cell research & therapy\| PubMed ID: 29361987	2018
Prediction of acute GVHD and relapse by metabolic biomarkers after allogeneic hematopoietic stem cell transplantation. JCI insight\| PubMed ID: 29720575	2018
Soluble interleukin-27 receptor alpha is a valuable prognostic biomarker for acute graft-versus-host disease after allogeneic haematopoietic stem cell transplantation. Scientific reports\| PubMed ID: 29985424	2018
First-in-man clinical trial of CAR NK-92 cells: safety test of CD33-CAR NK-92 cells in patients with relapsed and refractory acute myeloid leukemia. American journal of cancer research\| PubMed ID: 30034945	2018
Efficacy of Caspofungin in Unclassified Invasive Fungal Infection Cases: A Retrospective Analysis of Patients with Hematological Malignancies in China. Medical science monitor : international medical journal of experimental and clinical research\| PubMed ID: 30056458	2018
Successful treatment of secondary poor graft function post allogeneic hematopoietic stem cell transplantation with eltrombopag. Journal of hematology & oncology\| PubMed ID: 30115080	2018
Clinical and molecular features of acute promyelocytic leukemia with variant retinoid acid receptor fusions. Haematologica\| PubMed ID: 30237272	2019
Prognostic Significance of Platelet Recovery in Myelodysplastic Syndromes With Severe Thrombocytopenia. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis\| PubMed ID: 30296835	2018
Treating Steroid Refractory Intestinal Acute Graft-vs.-Host Disease With Fecal Microbiota Transplantation: A Pilot Study. Frontiers in immunology\| PubMed ID: 30319644	2018
Erratum: First-in-man clinical trial of CAR NK-92 cells: safety test of CD33-CAR NK-92 cells in patients with relapsed and refractory acute myeloid leukemia. American journal of cancer research\| PubMed ID: 30323981	2018
IL-17C Mitigates Murine Acute Graft-vs.-Host Disease by Promoting Intestinal Barrier Functions and Treg Differentiation. Frontiers in immunology\| PubMed ID: 30534126	2018
Ectopic ATP synthase β subunit proteins on human leukemia cell surface interact with platelets by binding glycoprotein IIb. Haematologica\| PubMed ID: 30733262	2019
Prognostic nomogram incorporating inflammatory cytokines for overall survival in patients with aggressive non-Hodgkin's lymphoma. EBioMedicine\| PubMed ID: 30827933	2019
Delayed remission following sequential infusion of humanized CD19- and CD22-modified CAR-T cells in a patient with relapsed/refractory acute lymphoblastic leukemia and prior exposure to muri... OncoTargets and therapy\| PubMed ID: 30988623	2019
Overexpression of ZEB2-AS1 lncRNA is associated with poor clinical outcomes in acute myeloid leukemia. Oncology letters\| PubMed ID: 31186703	2019
Tumor Vasculatures: A New Target for Cancer Immunotherapy. Trends in pharmacological sciences\| PubMed ID: 31331639	2019
Comparation of CART19 and autologous stem-cell transplantation for refractory/relapsed non-Hodgkin's lymphoma. JCI insight\| PubMed ID: 31335321	2019
Successful treatment of marrow failure after CARTs for myeloma by the infusion of cryopreserved stem cells. American journal of hematology\| PubMed ID: 31637745	2020
Measurable residual disease at myeloablative allogeneic transplantation in adults with acute lymphoblastic leukemia: a retrospective registry study on 2780 patients from the acute leukemia w... Journal of hematology & oncology\| PubMed ID: 31647022	2019
Prognostic effect of allogeneic hematopoietic stem cell transplantation on first and non-first complete remission in acute myeloid leukemia. Annals of translational medicine\| PubMed ID: 31700936	2019
High expression of DOCK2 indicates good prognosis in acute myeloid leukemia. Journal of Cancer\| PubMed ID: 31762818	2019
Fenretinide-induced Apoptosis of Acute Myeloid Leukemia Cells via NR4A1 Translocation into Mitochondria and Bcl-2 Transformation. Journal of Cancer\| PubMed ID: 31839811	2019
Efficacy of Posaconazole Prophylaxis for Fungal Disease in Hematology Patients Treated With Chemotherapy and Transplantation: An Open-Label, Prospective, Observational Study. Frontiers in microbiology\| PubMed ID: 32265849	2020
TBL1XR1 mutation predicts poor outcome in primary testicular diffuse large B-cell lymphoma patients. Biomarker research\| PubMed ID: 32322395	2020
The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China. Thrombosis research\| PubMed ID: 32407937	2020
Characterization of novel dual tandem CD19/BCMA chimeric antigen receptor T cells to potentially treat multiple myeloma. Biomarker research\| PubMed ID: 32435496	2020
Interleukin-6-knockdown of chimeric antigen receptor-modified T cells significantly reduces IL-6 release from monocytes. Experimental hematology & oncology\| PubMed ID: 32523801	2020
Analysis of hematological indexes of COVID-19 patients from fever clinics in Suzhou, China. International journal of laboratory hematology\| PubMed ID: 32657537	2020
Anti-bacterial and anti-viral nanchangmycin displays anti-myeloma activity by targeting Otub1 and c-Maf. Cell death & disease\| PubMed ID: 32999280	2020
Donor γδT Cells Promote GVL Effect and Mitigate aGVHD in Allogeneic Hematopoietic Stem Cell Transplantation. Frontiers in immunology\| PubMed ID: 33178187	2020
Investigation of the Potential Mechanism Governing the Effect of the on COVID-19 by Network Pharmacology. Evidence-based complementary and alternative medicine : eCAM\| PubMed ID: 33224256	2020
Safety and Efficacy of Moroctocog Alfa (AF-CC) in Chinese Patients with Hemophilia A: Results of Two Open-Label Studies. Journal of blood medicine\| PubMed ID: 33269010	2020
Identification of metabolic biomarkers to predict treatment outcome and disease progression in multiple myeloma. American journal of cancer research\| PubMed ID: 33294278	2020
IL-Y Aggravates Murine Chronic Graft--Host Disease by Enhancing T and B Cell Responses. Frontiers in immunology\| PubMed ID: 33329519	2020
Sequential CD19 and BCMA-specific CAR T-cell treatment elicits sustained remission of relapsed and/or refractory myeloma. Cancer medicine\| PubMed ID: 33356013	2021
Cytotoxic effect of CLL‑1 CAR‑T cell immunotherapy with PD‑1 silencing on relapsed/refractory acute myeloid leukemia. Molecular medicine reports\| PubMed ID: 33495835	2021
Efficacy and Safety of Eculizumab in the Treatment of Transplant-Associated Thrombotic Microangiopathy: A Systematic Review and Meta-Analysis. Frontiers in immunology\| PubMed ID: 33552043	2020
A multicenter, randomized phase III trial of hetrombopag: a novel thrombopoietin receptor agonist for the treatment of immune thrombocytopenia. Journal of hematology & oncology\| PubMed ID: 33632264	2021
Low-dose decitabine for refractory prolonged isolated thrombocytopenia after HCT: a randomized multicenter trial. Blood advances\| PubMed ID: 33646303	2021
Case Report: Reversible Neurotoxicity and a Clinical Response Induced by BCMA-Directed Chimeric Antigen Receptor T Cells Against Multiple Myeloma With Central Nervous System Involvement. Frontiers in immunology\| PubMed ID: 33717057	2021
Kupffer cell receptor CLEC4F is important for the destruction of desialylated platelets in mice. Cell death and differentiation\| PubMed ID: 33993195	2021
CD38-directed CAR-T cell therapy: a novel immunotherapy strategy for relapsed acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation. Journal of hematology & oncology\| PubMed ID: 34034795	2021
Splenic irradiation combined with plasmapheresis and rituximab: a new option reducing donor-specific antibody in haploidentical hematopoietic stem cell transplantation. Bone marrow transplantation\| PubMed ID: 36402923	2023
DLL1 orchestrates CD8 T cells to induce long-term vascular normalization and tumor regression. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 34035167	2021
Dynamic mRNA expression of donor-derived activating KIR genes and their significant effects on clinical outcome after haematopoietic stem cell transplantation. Clinical and experimental immunology\| PubMed ID: 34085290	2021
A Prospective Investigation of Bispecific CD19/22 CAR T Cell Therapy in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma. Frontiers in oncology\| PubMed ID: 34113569	2021
G Protein-Coupled Estrogen Receptor Agonist G-1 Inhibits Mantle Cell Lymphoma Growth in Preclinical Models. Frontiers in oncology\| PubMed ID: 34211844	2021
Safety and Efficacy of Fecal Microbiota Transplantation for Grade IV Steroid Refractory GI-GvHD Patients: Interim Results From FMT2017002 Trial. Frontiers in immunology\| PubMed ID: 34220825	2021
Efficiency and Toxicity of Ruxolitinib as a Salvage Treatment for Steroid-Refractory Chronic Graft-Versus-Host Disease. Frontiers in immunology\| PubMed ID: 34276662	2021
High stearic acid diet modulates gut microbiota and aggravates acute graft-versus-host disease. Signal transduction and targeted therapy\| PubMed ID: 34294684	2021
Allogeneic hematopoietic stem cell transplantation from non-sibling 10/10 HLA-matched related donors: a single-center experience. Haematologica\| PubMed ID: 34320787	2021
SPOP-mediated ubiquitination and degradation of PDK1 suppresses AKT kinase activity and oncogenic functions. Molecular cancer\| PubMed ID: 34353330	2021
Real-world assessment of the effectiveness of posaconazole for the prophylaxis and treatment of invasive fungal infections in hematological patients: A retrospective observational study. Medicine\| PubMed ID: 34397725	2021
The Prognostic Value of Early Detection of Minimal Residual Disease as Defined by Flow Cytometry and Gene Mutation Clearance for Myelodysplastic Syndrome Patients After Myeloablative Allogen... Frontiers in oncology\| PubMed ID: 34422653	2021
Epstein-Barr virus and cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation in patients with non-Hodgkin lymphoma: the prevalence and impacts on outcomes : EBV an... Annals of hematology\| PubMed ID: 34480615	2021
Inefficacy of Immunosuppressive Therapy for Severe Aplastic Anemia Progressing From Non-SAA: Improved Outcome After Allogeneic Hematopoietic Stem Cell Transplantation. Frontiers in oncology\| PubMed ID: 34621679	2021
Development of a Nomogram for Predicting the Cumulative Incidence of Disease Recurrence of AML After Allo-HSCT. Frontiers in oncology\| PubMed ID: 34646774	2021
Roles of the intestinal microbiota and microbial metabolites in acute GVHD. Experimental hematology & oncology\| PubMed ID: 34706782	2021
A comprehensive approach to stool donor screening for faecal microbiota transplantation in China. Microbial cell factories\| PubMed ID: 34838016	2021
Maternal and Fetal Outcomes of Acute Leukemia in Pregnancy: A Retrospective Study of 52 Patients. Frontiers in oncology\| PubMed ID: 34970499	2021
The differential effects of tumor burdens on predicting the net benefits of ssCART-19 cell treatment on r/r B-ALL patients. Scientific reports\| PubMed ID: 35013456	2022
Characterization of m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration in acute myeloid leukemia. Cancer medicine\| PubMed ID: 35023630	2022
Initial Treatment Patterns and Survival Outcomes of Mantle Cell Lymphoma Patients Managed at Chinese Academic Centers in the Rituximab Era: A Real-World Study. Frontiers in oncology\| PubMed ID: 35059312	2021
Comparable Outcomes and Health-Related Quality of Life for Severe Aplastic Anemia: Haploidentical Combined With a Single Cord Blood Unit Matched Related Transplants. Frontiers in oncology\| PubMed ID: 35117985	2021
Functional Evaluation of KEL as an Oncogenic Gene in the Progression of Acute Erythroleukemia. Oxidative medicine and cellular longevity\| PubMed ID: 35140839	2022
Allogeneic Stem Cell Transplantation Combined With Transfusion of Mesenchymal Stem Cells in Primary Myelofibrosis: A Multicenter Retrospective Study. Frontiers in oncology\| PubMed ID: 35141151	2021
Phase 1b/3 Pharmacokinetics and Safety Study of Intravenous Posaconazole in Adult Asian Participants at High Risk for Invasive Fungal Infections. Advances in therapy\| PubMed ID: 35167031	2022
Safety and efficacy of hetrombopag in patients with chronic immune thrombocytopenia: a single-arm, open-label, multi-center phase 1 study. Annals of translational medicine\| PubMed ID: 35282136	2022
Chimeric antigen receptors containing the OX40 signalling domain enhance the persistence of T cells even under repeated stimulation with multiple myeloma target cells. Journal of hematology & oncology\| PubMed ID: 35365211	2022
Identification of the Predictive Models for the Treatment Response of Refractory/Relapsed B-Cell ALL Patients Receiving CAR-T Therapy. Frontiers in immunology\| PubMed ID: 35371098	2022
Blocking human protein C anticoagulant activity improves clotting defects of hemophilia mice expressing human protein C. Blood advances\| PubMed ID: 35390147	2022
High-choline diets ameliorate acute graft-versus-host disease. Blood science (Baltimore, Md.)\| PubMed ID: 35400024	2020
Overall survival benefits provided by lenalidomide maintenance after chimeric antigen receptor T cell therapy in patients with refractory/relapsed diffuse large B-cell lymphoma. Annals of translational medicine\| PubMed ID: 35433994	2022
Case Report: A Case of Acute T Lymphoblastic Leukemia With Mixed Infection of Lethal Invasive Mucormycosis and Multi-Drug Resistant Bacteria. Frontiers in medicine\| PubMed ID: 35479945	2022
The Clinical Value of Procalcitonin in the Neutropenic Period After Allogeneic Hematopoietic Stem Cell Transplantation. Frontiers in immunology\| PubMed ID: 35547733	2022
Features of Epstein-Barr Virus and Cytomegalovirus Reactivation in Acute Leukemia Patients After Haplo-HCT With Myeloablative ATG-Containing Conditioning Regimen. Frontiers in cellular and infection microbiology\| PubMed ID: 35651756	2022
IL-39 promotes chronic graft-versus-host disease by increasing T and B Cell pathogenicity. Experimental hematology & oncology\| PubMed ID: 35655245	2022
Prognostic value of dynamic cardiac biomarkers in patients with acquired refractory thrombocytopenic purpura: A retrospective study in Chinese population. Journal of clinical laboratory analysis\| PubMed ID: 35689538	2022
2021 Chinese consensus on the diagnosis and management of primary immune thrombocytopenia in pregnancy. Chinese medical journal\| PubMed ID: 35730369	2022
The Clinical Characteristics and Prognosis of AYA and Older Adult ETP-ALL/LBL: A Real-World Multicenter Study in China. Frontiers in oncology\| PubMed ID: 35734596	2022
Haploidentical vs matched sibling donor transplant for paroxysmal nocturnal haemoglobinuria: A multicenter study. Blood cancer journal\| PubMed ID: 35750668	2022
Fucosylation Promotes Cytolytic Function and Accumulation of NK Cells in B Cell Lymphoma. Frontiers in immunology\| PubMed ID: 35784355	2022
The clinical application of SNP-based next-generation sequencing (SNP-NGS) for evaluation of chimerism and microchimerism after HLA-mismatched stem cell microtransplantation. International journal of hematology\| PubMed ID: 35802296	2022
FEV Maintains Homing and Expansion by Activating ITGA4 Transcription in Primary and Relapsed AML. Frontiers in oncology\| PubMed ID: 35875066	2022
Prognostic Value of Thrombocytopenia in Myelodysplastic Syndromes After Hematopoietic Stem Cell Transplantation. Frontiers in oncology\| PubMed ID: 35898899	2022
Recurrent Novel Translocations in B-Lymphoblastic Leukemia/Lymphoma. Frontiers in oncology\| PubMed ID: 35912172	2022
Matched related transplantation versus immunosuppressive therapy plus eltrombopag for first-line treatment of severe aplastic anemia: a multicenter, prospective study. Journal of hematology & oncology\| PubMed ID: 35962406	2022
Chinese expert consensus on the management of chimeric antigen receptor T cell therapy-associated coagulopathy. Chinese medical journal\| PubMed ID: 35984103	2022
Decitabine-primed tandem CD19/CD22 CAR-T therapy in relapsed/refractory diffuse large B-cell lymphoma patients. Frontiers in immunology\| PubMed ID: 36059523	2022
The impact of Rituximab administered before transplantation in patients undergoing allogeneic hematopoietic stem cell transplantation: A real-world study. Frontiers in immunology\| PubMed ID: 36119024	2022
Cytopenia after chimeric antigen receptor T cell immunotherapy in relapsed or refractory lymphoma. Frontiers in immunology\| PubMed ID: 36131934	2022
Severe aplastic anemia patients with infection who received an allogeneic hematopoietic stem cell transplantation had a better chance: Long-term outcomes of a multicenter study. Frontiers in immunology\| PubMed ID: 36131940	2022
Chinese expert consensus on oral drugs for the treatment of mature B-cell lymphomas (2020 edition). Frontiers of medicine\| PubMed ID: 36152123	2022
CD7-directed CAR T-cell therapy: a potential immunotherapy strategy for relapsed/refractory acute myeloid leukemia. Experimental hematology & oncology\| PubMed ID: 36175988	2022
Avatrombopag for the treatment of thrombocytopenia post hematopoietic stem-cell transplantation. Therapeutic advances in hematology\| PubMed ID: 36185780	2022
Case report: Rare persistent complete donor chimerism and GVHD following micro-transplantation from HLA haplotype homozygous donors. Frontiers in immunology\| PubMed ID: 36189257	2022
The safety and short-term outcomes of allogeneic hematopoietic stem cell transplantation with donor vaccination for COVID-19. MedComm\| PubMed ID: 36226252	2022
The independent adverse prognostic significance of 1q21 gain/amplification in newly diagnosed multiple myeloma patients. Frontiers in oncology\| PubMed ID: 36276097	2022
Fecal microbiota transplantation combined with ruxolitinib as a salvage treatment for intestinal steroid-refractory acute GVHD. Experimental hematology & oncology\| PubMed ID: 36352455	2022
is a potential prognostic biomarker and may be correlated with immune infiltration and ferroptosis in acute myeloid leukemia: a pan-cancer analysis. Translational cancer research\| PubMed ID: 36388050	2022
Successful treatment of severe cytokine release syndrome after CAR-T therapy by ruxolitinib without compromising CAR-T efficacy. Leukemia & lymphoma\| PubMed ID: 36395278	2023
Hematopoietic Stem Cell Transplantation Activity in China 2020-2021 During the SARS-CoV-2 Pandemic: A Report From the Chinese Blood and Marrow Transplantation Registry Group. Transplantation and cellular therapy\| PubMed ID: 36402457	2023
Transcriptome-based molecular subtypes and differentiation hierarchies improve the classification framework of acute myeloid leukemia. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 36442087	2022
[Comparison of Therapeutic Efficacy between Hypomenthylating Agents Combined with Venetoclax and Half Dose Priming Regimen in Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia]. Zhongguo shi yan xue ye xue za zhi\| PubMed ID: 36476881	2022
Case report: CD38-directed CAR-T cell therapy: A novel immunotherapy targeting CD38- positive blasts overcomes TKI and chemotherapy resistance of myeloid chronic myeloid leukemia in blastic ... Frontiers in immunology\| PubMed ID: 36524116	2022
Bendamustine in the treatment of patients with indolent non-Hodgkin lymphoma refractory or relapse to rituximab treatment: An open-label, single-agent, multicenter study in China. Cancer\| PubMed ID: 36541221	2023
Long-term follow-up of haploidentical transplantation in relapsed/refractory severe aplastic anemia: a multicenter prospective study. Science bulletin\| PubMed ID: 36546031	2022
The OTUD1-Notch2-ICD axis orchestrates allogeneic T cell-mediated graft-versus-host disease. Blood\| PubMed ID: 36574342	2023
The efficiency of human umbilical cord mesenchymal stem cells as a salvage treatment for steroid-refractory acute graft-versus-host disease. Clinical and experimental medicine\| PubMed ID: 36598673	2023
Autologous stem cell transplantation in multiple myeloma patients with renal impairment. Annals of hematology\| PubMed ID: 36633638	2023
Safety and performance of the Spectra Optia apheresis system for white blood cell depletion in patients with elevated white blood cell counts. Journal of clinical apheresis\| PubMed ID: 36655281	2023
Evaluation of the Diagnostic Performance of Plasma Metagenomic Next-Generation Sequencing in Febrile Events in the First 30 Days after Chimeric Antigen Receptor T Cell Infusion. Transplantation and cellular therapy\| PubMed ID: 36724855	2023
Combination venetoclax and olverembatinib (HQP1351) as a successful therapeutic strategy for relapsed/refractory (R/R) mixed-phenotype blast phase of chronic myeloid leukemia. Annals of hematology\| PubMed ID: 36745193	2023
CAR-T cell therapy followed by allogenic hematopoietic stem cell transplantation yielded comparable outcome between Ph like ALL and other high-risk ALL. Biomarker research\| PubMed ID: 36793095	2023
USP11 plays a critical role in the onset and progression of acute graft-versus-host disease：Novel target for precision therapeutics. Pharmacological research\| PubMed ID: 36822452	2023
2022 Chinese expert consensus and guidelines on clinical management of toxicity in anti-CD19 chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma. Cancer biology & medicine\| PubMed ID: 36861439	2023
Guidelines for the diagnosis, treatment, prevention and control of infections caused by carbapenem-resistant gram-negative bacilli. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi\| PubMed ID: 36868960	2023
Conditioning therapy with N-acetyl-L-cysteine, decitabine and modified BUCY regimen for myeloid malignancies patients prior to allogeneic hematopoietic stem cell transplantation. American journal of hematology\| PubMed ID: 36880836	2023
Anti-CD19 CAR T-cell consolidation therapy combined with CD19+ feeding T cells and TKI for Ph+ acute lymphoblastic leukemia. Blood advances\| PubMed ID: 36897251	2023
Adenovirus infection diagnosed by metagenomic next-generation sequencing after haploidentical hematopoietic stem cell transplantation: A multicenter study in China. Transplant infectious disease : an official journal of the Transplantation Society\| PubMed ID: 36908212	2023
Appropriate pre-transplant strategy for patients with myelodysplastic syndromes receiving allogeneic haematopoietic stem cell transplantation after myeloablative conditioning. Frontiers in immunology\| PubMed ID: 36926344	2023
Similar outcomes following non-first-degree and first-degree related donor haploidentical hematopoietic cell transplantation for acute leukemia patients in complete remission: a study from t... Journal of hematology & oncology\| PubMed ID: 36934271	2023
RUNX1 together with DAT mutations predicted poor outcome in acute myeloid leukemia. Leukemia & lymphoma\| PubMed ID: 36964663	2023
Clinical characteristics and prognostic significance of DNA methylation regulatory gene mutations in acute myeloid leukemia. Clinical epigenetics\| PubMed ID: 36991512	2023
Decitabine in combination with fludarabine and cyclophosphamide as a lymphodepletion regimen followed by CD19/CD22 bispecific targeted CAR T-cell therapy significantly improves survival in r... Experimental hematology & oncology\| PubMed ID: 37038230	2023
Physicians' knowledge of invasive fungal disease in China. Mycoses\| PubMed ID: 37059587	2023
Immunosuppressive tumor microenvironment contributes to tumor progression in diffuse large B-cell lymphoma upon anti-CD19 chimeric antigen receptor T therapy. Frontiers of medicine\| PubMed ID: 37060525	2023
Expert consensus on microtransplant for acute myeloid leukemia in elderly patients -report from the international microtransplant interest group. Heliyon\| PubMed ID: 37089296	2023
Which one is better for refractory/relapsed acute B-cell lymphoblastic leukemia: Single-target (CD19) or dual-target (tandem or sequential CD19/CD22) CAR T-cell therapy? Blood cancer journal\| PubMed ID: 37095120	2023
Safety and efficacy of CD22 and CD19 CAR-T bridging auto-HSCT as consolidation therapy for AYA and adult B-ALL. Blood cancer journal\| PubMed ID: 37137904	2023
Causative germline variant p.Y259C of DDX41 recurrently identified in acute lymphoblastic leukaemia. British journal of haematology\| PubMed ID: 37144604	2023
Allogeneic hematopoietic stem cell transplantation for NK/T-cell lymphoma: an international collaborative analysis. Leukemia\| PubMed ID: 37157017	2023
CD19 chimeric antigen receptor T-cell therapy in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia without complete molecular response at 3 months. Blood cancer journal\| PubMed ID: 37164955	2023
Acute liver failure associated with human adenovirus infection after allogeneic hematopoietic stem cell transplantation. Annals of hematology\| PubMed ID: 37178390	2023
Outcomes of adult patients with type 1 primary refractory acute myeloid leukemia: a single center experience. Hematology (Amsterdam, Netherlands)\| PubMed ID: 37191301	2023
Efficacy and Safety Analysis of Combination Therapy Consisting of Intravenous Immunoglobulin and Corticosteroids versus Respective Monotherapies in the Treatment of Relapsed ITP in Adults. Global medical genetics\| PubMed ID: 37228869	2023
Mutation spectrum of FLT3 and significance of non-canonical FLT3 mutations in haematological malignancy. British journal of haematology\| PubMed ID: 37246158	2023
Exploration of efficacy and safety of combined therapy of basiliximab with ruxolitinib for grade 3-4 steroid-refractory acute graft-versus-host disease: a registered clinical trial (NCT05021... Bone marrow transplantation\| PubMed ID: 37253803	2023
Epidemiology, treatment patterns, and disease burden of cytomegalovirus in hematopoietic cell transplant recipients in selected countries outside of Europe and North America: A systematic re... Transplant infectious disease : an official journal of the Transplantation Society\| PubMed ID: 37287436	2023
Efficacy and safety of chimeric antigen receptor T cell therapy in relapsed/refractory diffuse large B-cell lymphoma with different HBV status: a retrospective study from a single center. Frontiers in immunology\| PubMed ID: 37292195	2023
Safety and efficacy of an anti-human APC antibody for prophylaxis of congenital factor deficiencies in preclinical models. Blood\| PubMed ID: 37294924	2023
The efficacy of first salvage therapy determines the outcomes of adult patients with type 1 primary refractory acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation... Annals of hematology\| PubMed ID: 37301787	2023
Long-term Complete Remission of Decitabine-Primed Tandem CD19/CD22 CAR-T Therapy with PD-1 and BTK Inhibitors Maintenance in a Refractory Primary Central Nervous System Lymphoma Patient. Cancer research and treatment\| PubMed ID: 37321275	2023
Chimeric antigen receptor T cells targeting FcRH5 provide robust tumour-specific responses in murine xenograft models of multiple myeloma. Nature communications\| PubMed ID: 37339964	2023
Identification and validation of a 7-genes prognostic signature for adult acute myeloid leukemia based on aging-related genes. Aging\| PubMed ID: 37367950	2023
Critical role of MXRA7 in differentiation blockade in human acute promyelocytic leukemia cells. Experimental hematology\| PubMed ID: 37419299	2023
Advances in graft-versus-host disease prevention strategies: latest updates from the 2022 ASH annual meeting. Experimental hematology & oncology\| PubMed ID: 37420283	2023
Dose-escalating ruxolitinib for refractory hemophagocytic lymphohistiocytosis. Frontiers in immunology\| PubMed ID: 37457729	2023
Combination of venetoclax with BCR-ABL tyrosine kinase inhibitor as a therapeutic strategy for Philadelphia chromosome-positive leukemias. Hematology (Amsterdam, Netherlands)\| PubMed ID: 37477259	2023
Venetoclax with decitabine as frontline treatment in younger adults with newly diagnosed ELN adverse-risk AML. Blood\| PubMed ID: 37478399	2023
The clinical value of anal swabs for microbial detection in allogeneic haematopoietic stem cell transplantation. Transplantation and cellular therapy\| PubMed ID: 37499872	2023
Development of a scoring system for predicting primary resistance to venetoclax plus hypomethylating agents (HMAs) in acute myeloid leukemia patients. Molecular carcinogenesis\| PubMed ID: 37555764	2023
Sustained Response to Ruxolitinib of Eosinophilia-Associated Myeloproliferative Neoplasm with Translocation t(8;9)(p21;p24). Acta haematologica\| PubMed ID: 37562364	2023
Romiplostim in primary immune thrombocytopenia that is persistent or chronic: phase III multicenter, randomized, placebo-controlled clinical trial in China. Research and practice in thrombosis and haemostasis\| PubMed ID: 37601010	2023
Master kinase PDK1 in tumorigenesis. Biochimica et biophysica acta. Reviews on cancer\| PubMed ID: 37640147	2023
Autologous stem cell transplantation in adult patients with intermediate-risk acute myeloid leukemia in first complete remission and no detectable minimal residual disease. A comparative ret... Bone marrow transplantation\| PubMed ID: 37640797	2023
Ceftazidime reduces cellular Skp2 to promote type-I interferon activity. Immunology\| PubMed ID: 37641430	2023
Long-term follow-up of tandem CD19/CD22 CAR T-Cells in r/r B-ALL patients with high-risk features. American journal of hematology\| PubMed ID: 37665759	2023
Cell-free DNA chromosome copy number variations predict outcomes in plasma cell myeloma. Blood cancer journal\| PubMed ID: 37669974	2023
Tandem bispecific CD123/CLL-1 CAR-T cells exhibit specific cytolytic effector functions against human acute myeloid leukaemia. European journal of haematology\| PubMed ID: 37712633	2024
Efficacy of venetoclax combined with hypomethylating agents in young, and unfit patients with newly diagnosed core binding factor acute myeloid leukemia. Blood cancer journal\| PubMed ID: 37821435	2023
Busulfan/Cyclophosphamide Compared with Melphalan as a Conditioning Regimen for Autologous Transplantation of Multiple Myeloma: A Long-Term Assessment. Journal of clinical medicine\| PubMed ID: 37834886	2023
Assessment of risk factors for acute graft--host disease post-hematopoietic stem cell transplantation: a retrospective study based on a proportional odds model using a nonlinear mixed-effect... Therapeutic advances in hematology\| PubMed ID: 37872970	2023
CD19/CD22 dual-targeting chimeric antigen receptor T-cell therapy bridging to allogeneic haematopoietic stem cell transplantation for B-cell acute lymphoblastic leukaemia delays platelet rec... Clinical and translational medicine\| PubMed ID: 37882317	2023
Risk Factors for Carbapenem-Resistant Colonization and the Effect on Clinical Outcomes and Prognosis in Allogeneic Hematopoietic Stem Cell Transplanted Patients. Infection and drug resistance\| PubMed ID: 37904832	2023
Prognostic significance of persisting DNMT3A, ASXL1, and TET2 mutation burden in acute myeloid leukemia patients with allogeneic hematopoietic stem cell transplantation during complete remis... Leukemia & lymphoma\| PubMed ID: 37990829	2024
Venetoclax plus hypomethylating agents in newly diagnosed acute myeloid leukemia patients with RUNX1::RUNX1T1: a retrospective propensity score matching study. Blood cancer journal\| PubMed ID: 38012154	2023
The impact of pre-transplant anti-HLA antibodies in transplants from HLA-identical sibling donors: A multicenter study. HLA\| PubMed ID: 38018476	2024
Integrated analysis of single-cell RNA-seq and bulk RNA-seq reveals RNA N6-methyladenosine modification associated with prognosis and drug resistance in acute myeloid leukemia. Frontiers in immunology\| PubMed ID: 38022588	2023
Outcomes of venetoclax combined with homoharringtonine and cytarabine in fit adults patients with de novo adverse-risk acute myeloid leukaemia: A single-centre retrospective analysis. EJHaem\| PubMed ID: 38024627	2023
Myelodysplastic syndrome associated-haemophagocytic lymphohistiocytosis: A retrospective study of 15 cases in a single centre. British journal of haematology\| PubMed ID: 38036428	2024
Circulating tumor DNA determining hyperprogressive disease after CAR-T therapy alarms in DLBCL: a case report and literature review. Frontiers in oncology\| PubMed ID: 38090479	2023
Identification of a venetoclax-resistance prognostic signature base on 6-senescence genes and its clinical significance for acute myeloid leukemia. Frontiers in oncology\| PubMed ID: 38098504	2023
A clinical predictive model for pre-transplantation colonization and relevance for clinical outcomes in patients receiving allogeneic hematopoietic stem cell transplantation. Microbiology spectrum\| PubMed ID: 38189331	2024
Clinical Efficacy and Safety of Colistin Sulfate in the Treatment of Carbapenem-Resistant Organism Infections in Patients with Hematological Diseases. Infectious diseases and therapy\| PubMed ID: 38212555	2024
RNA-binding protein RBM5 plays an essential role in acute myeloid leukemia by activating the oncogenic protein HOXA9. Genome biology\| PubMed ID: 38216972	2024
The indirect effects of CMV reactivation on patients following allogeneic hematopoietic stem cell transplantation: an evidence mapping. Annals of hematology\| PubMed ID: 38227006	2024
Outcomes of allogeneic hematopoietic stem cell transplantation in R/R DLBCL patients with failure of CAR-T therapy. Experimental hematology & oncology\| PubMed ID: 38229150	2024
Current situation and development of hematopoietic cell transplantation centers: A nationwide survey in China. Chinese medical journal\| PubMed ID: 38251709	2024
Allogenic hematopoietic stem cell transplantation outcomes of patients aged ≥ 55 years with acute myeloid leukemia or myelodysplastic syndromes in China: a retrospective study. Stem cell research & therapy\| PubMed ID: 38282037	2024
Successful treatment of a B/T MPAL patient by chemo-free treatment with venetoclax, azacitidine, and blinatumomab. Annals of hematology\| PubMed ID: 38367057	2024
Successful Treatment of Refractory EBV-Associated Hemophagocytic Lymphohistiocytosis with Combined Emapalumab and PD-1 Blockade. Journal of clinical immunology\| PubMed ID: 38400989	2024
Aging and comprehensive molecular profiling in acute myeloid leukemia. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 38422020	2024
Unrelated donor hematopoietic stem cell transplantation compared to immunosuppressive therapy plus eltrombopag as first-line treatment for adults with severe aplastic anemia. Blood cancer journal\| PubMed ID: 38443356	2024
Clinical outcomes of patients with lymphoid blastic phase of chronic myeloid leukemia treated with CAR T-cell therapy. Blood cancer journal\| PubMed ID: 38448401	2024
Comparison of valganciclovir foscarnet for the treatment of cytomegalovirus viremia in adult acute leukemia patients after allogeneic hematopoietic cell transplantation. Leukemia & lymphoma\| PubMed ID: 38475670	2024
Hematologic health services and practical characteristics: report of a nationwide survey among Chinese hematologists. BMC health services research\| PubMed ID: 38475797	2024
Different dosage regimens of zuranolone in the treatment of major depressive disorder: A meta-analysis of randomized controlled trials. Journal of affective disorders\| PubMed ID: 38479510	2024
Evaluation of next-generation sequencing versus next-generation flow cytometry for minimal-residual-disease detection in Chinese patients with multiple myeloma. Discover oncology\| PubMed ID: 38502423	2024
A phase II study of belumosudil for chronic graft-versus-host disease in patients who failed at least one line of systemic therapy in China. BMC medicine\| PubMed ID: 38532458	2024
Chinese expert consensus on integrated case management by a multidisciplinary team in CAR-T cell therapy for lymphoma. Chinese medical journal\| PubMed ID: 38570196	2024
Busulfan plus cyclophosphamide vs. total body irradiation plus cyclophosphamide for allogeneic hematopoietic stem cell transplantation in patients with acute T lymphoblastic leukemia: a larg... Bone marrow transplantation\| PubMed ID: 38615141	2024
Shared genetic architecture between autoimmune disorders and B-cell acute lymphoblastic leukemia: insights from large-scale genome-wide cross-trait analysis. BMC medicine\| PubMed ID: 38616254	2024
Combined emapalumab and ruxolitinib in patients with haemophagocytic Lymphohistiocytosis. Blood cancer journal\| PubMed ID: 38658542	2024
[Effect of Recombinant Human Thrombopoietin on Platelet Reconstitution after Autologous Peripheral Blood Stem Cell Transplantation in Patients with Multiple Myeloma]. Zhongguo shi yan xue ye xue za zhi\| PubMed ID: 38660859	2024
Real-world evidence on treatment pattern, effectiveness, and safety of blinatumomab in Chinese patients with B-cell acute lymphoblastic leukemia. Investigational new drugs\| PubMed ID: 38662275	2024
Rituximab potentially improves clinical outcomes of CAR-T therapy for r/r B-ALL via sensitizing leukemia cells to CAR-T-mediated cytotoxicity and reducing CAR-T exhaustion. Cellular oncology (Dordrecht, Netherlands)\| PubMed ID: 38662336	2024
Mini-dose methotrexate combined with methylprednisolone for the initial treatment of acute GVHD: a multicentre, randomized trial. BMC medicine\| PubMed ID: 38664766	2024
Haploidentical hematopoietic cell transplantation with or without an unrelated cord blood unit for adult acute myeloid leukemia: a multicenter, randomized, open-label, phase 3 trial. Signal transduction and targeted therapy\| PubMed ID: 38705885	2024
The Role of Pre-existing Anti-HLA Antibodies in Severe Aplastic Anemia Patients Undergoing Allogenic Hematopoietic Stem Cell Transplantation. Transplantation and cellular therapy\| PubMed ID: 38740139	2024
Impact of cladribine, cytarabine, and G-CSF (CLAG) as a bridging therapy prior to allogeneic hematopoietic stem cell transplantation in relapsed or refractory acute myeloid leukemia. Annals of hematology\| PubMed ID: 38758360	2024
PD-1 blockade immunotherapy as a successful rescue treatment for disseminated adenovirus infection after allogeneic hematopoietic stem cell transplantation. Journal of hematology & oncology\| PubMed ID: 38764055	2024
Switching from eltrombopag to hetrombopag in patients with primary immune thrombocytopenia: a post-hoc analysis of a multicenter, randomized phase III trial. Annals of hematology\| PubMed ID: 38842566	2024
Risk factors and molecular epidemiology of intestinal colonization by carbapenem-resistant Gram-negative bacteria in patients with hematological diseases: a multicenter case‒control study. Microbiology spectrum\| PubMed ID: 38847538	2024
Application of omics in the diagnosis, prognosis, and treatment of acute myeloid leukemia. Biomarker research\| PubMed ID: 38858750	2024
HLA-DPB1 and DPA1 ~ DPB1 linkage mismatch affects the survival of recipients receiving HLA-14/14 matched unrelated donor HSCT. HLA\| PubMed ID: 38887889	2024
Haploidentical-cord blood stem cell transplantation versus haploidentical stem cell transplantation for non-CR acute leukemia patients: a multicenter study. Bone marrow transplantation\| PubMed ID: 38898225	2024
Chidamide combined with a modified Bu-Cy conditioning regimen improves survival in patients with T-cell acute lymphoblastic leukemia/lymphoma undergoing allogeneic hematopoietic stem cell tr... Annals of hematology\| PubMed ID: 38900303	2024
Patient-reported physical well-being predicts good long-term survival of hematopoietic stem cell transplantation. Cancer medicine\| PubMed ID: 38967515	2024
Consensus for antifungal stewardship in China (2024 edition). Journal of thoracic disease\| PubMed ID: 38983176	2024
Evidence-based expert consensus on clinical management of safety of Bruton's tyrosine kinase inhibitors (2024). Chinese journal of cancer research = Chung-kuo yen cheng yen chiu\| PubMed ID: 38988488	2024
Improved prevention and treatment strategies for differentiation syndrome contribute to reducing early mortality in patients with acute promyelocytic leukemia. Blood cancer journal\| PubMed ID: 39009567	2024
Overexpression of REC8 induces aberrant gamete meiotic division and contributes to AML pathogenesis - a multiplexed microarray analysis and mendelian randomization study. Annals of hematology\| PubMed ID: 39012516	2024
DIAPH1 mutations predict a favorable outcome for de novo MDS. Cancer letters\| PubMed ID: 39084456	2024
Comparison of efficacy of eltrombopag combined with immunosuppression in the treatment of severe aplastic anemia and very severe aplastic anemia: real-world data and evidence. Annals of hematology\| PubMed ID: 39088061	2024
First-line treatment of severe aplastic anemia: immunosuppressive therapy plus eltrombopag versus haploidentical hematopoietic stem cell transplantation, a multicenter prospective study. Bone marrow transplantation\| PubMed ID: 39090437	2024
Prognostic mutations identified by whole-exome sequencing and validation of the Molecular International Prognostic Scoring System in myelodysplastic syndromes after allogeneic haematopoietic... British journal of haematology\| PubMed ID: 39138006	2024
CD19 CAR T-cell therapy in relapsed TCF3-HLF-positive B-cell acute lymphoblastic leukemia. Annals of hematology\| PubMed ID: 39145779	2024
Safety and efficacy of blinatumomab as bridge-to-transplant for B-cell acute lymphoblastic leukemia in first complete remission with no detectable minimal residual disease. Blood cancer journal\| PubMed ID: 39179531	2024
YAP1 regulates thrombopoiesis by binding to MYH9 in immune thrombocytopenia. Blood\| PubMed ID: 39190466	2024
Decitabine consolidation after CD19/CD22 CAR-T therapy as a novel maintenance treatment significantly improves survival outcomes in relapsed/refractory B-ALL patients. Leukemia research\| PubMed ID: 39208598	2024
Reduced-dose chemotherapy and blinatumomab as induction treatment for newly diagnosed Ph-negative B-cell precursor acute lymphoblastic leukemia: a phase 2 trial. Journal of hematology & oncology\| PubMed ID: 39218935	2024
Genome-wide CRISPR/Cas9 library screening identified OGDH as a regulator of disease progress and resistance to decitabine in myelodysplastic neoplasm by reprogramming glutamine metabolism. Leukemia\| PubMed ID: 39227691	2024
Clinical trial: Chidamide plus CHOP improve the survival of newly diagnosed angioimmunoblastic T-cell lymphoma. Frontiers in immunology\| PubMed ID: 39229263	2024
The combination of a tyrosine kinase inhibitor and blinatumomab in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia or Philadelphia chromosome-like acute lymphobla... Cancer medicine\| PubMed ID: 39240182	2024
Familial Acute Promyelocytic Leukemia: A Case Report and Review of the Literature. OncoTargets and therapy\| PubMed ID: 39247121	2024
Hematopoietic stem cell transplantation activity in China 2022-2023. The proportions of peripheral blood for stem cell source continue to grow: a report from the Chinese Blood and Marrow Tra... Bone marrow transplantation\| PubMed ID: 39322652	2024
Consensus on the monitoring, treatment, and prevention of leukaemia relapse after allogeneic haematopoietic stem cell transplantation in China: 2024 update. Cancer letters\| PubMed ID: 39332587	2024
Network pharmacology-based investigation and experimental validation of the mechanism of metformin in the treatment of acute myeloid leukemia. European journal of medical research\| PubMed ID: 39343915	2024
Construction and Validation of an Assistant Decision-Making Model for Platelet Transfusion Refractoriness in Patients with Acute Myeloid Leukemia. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis\| PubMed ID: 39370845	2024
Safe and potent anti-CD19 CAR T-cells with shRNA-IL-6 gene silencing element in patients with refractory or relapsed B-cell acute lymphoblastic leukemia. HemaSphere\| PubMed ID: 39380843	2024
Increased Epstein‒Barr virus reactivation following prophylaxis for cytomegalovirus infection after haploidentical haematopoietic stem cell transplantation. Journal of hematology & oncology\| PubMed ID: 39396017	2024
Successful combined venetoclax to PD-1 blockade and ruxolitinib for refractory Epstein-Barr virus-associated haemophagocytic lymphohistiocytosis. British journal of haematology\| PubMed ID: 39520230	2025
Correction: Hematopoietic stem cell transplantation activity in China 2022-2023. The proportions of peripheral blood for stem cell source continue to grow: a report from the Chinese Blood an... Bone marrow transplantation\| PubMed ID: 39548309	2025
Dimethyl fumarate ameliorates chronic graft-versus-host disease by inhibiting Tfh differentiation via Nrf2. Leukemia\| PubMed ID: 39580582	2025
Efficacy of emapalumab in the management of anti‑CD19 chimeric antigen receptor T‑cell therapy‑associated cytokine release syndrome: A report of two cases. Oncology letters\| PubMed ID: 39628826	2025
Clinical outcomes and safety of CAR-T cells in treatment of T-Cell acute lymphoblastic leukemia/lymphoma. Annals of hematology\| PubMed ID: 39692783	2025
Case report: CAR-T therapy demonstrated safety and efficacy in relapsed/refractory diffuse large B-cell lymphoma patients complicated with hepatitis B-related cirrhosis. Frontiers in oncology\| PubMed ID: 39703853	2024
Impaired megakaryopoiesis due to aberrant macrophage polarization via BTK/Rap1/NF-κB pathway in sepsis-induced thrombocytopenia. Molecular therapy : the journal of the American Society of Gene Therapy\| PubMed ID: 39741411	2025
[Clinical Characteristics of Pneumocystis Jiroveci Pneumonia after Allogeneic Hematopoietic Stem Cell Transplantation]. Zhongguo shi yan xue ye xue za zhi\| PubMed ID: 39743281	2024
CPSF6-RARγ interacts with histone deacetylase 3 to promote myeloid transformation in RARG-fusion acute myeloid leukemia. Nature communications\| PubMed ID: 39805830	2025
Usp11 maintained the survival of marginal zone B cells under ionizing radiation by deubiquitinating DLL1 and JAG2. Cell death & disease\| PubMed ID: 39904982	2025
Efficacy and safety of CAR-T cell therapy in B-ALL patients previously treated with blinatumomab. Blood cancer journal\| PubMed ID: 39910042	2025
Comparing the efficacy and safety of venetoclax combined with hypomethylating agents versus intensive chemotherapy as induction therapy in newly diagnosed core binding factor acute myeloid l... Blood cancer journal\| PubMed ID: 39934109	2025
A comparison of porcine anti-human T lymphocyte immunoglobulin, rabbit-ATG for GVHD prophylaxis and without ATG in matched sibling donor transplantation. Current research in translational medicine\| PubMed ID: 39970787	2025
A 2D-STI echocardiographic diagnostic model established for cardiac amyloidosis complicated with multiple myeloma. International journal of cardiology\| PubMed ID: 39970960	2025
Venetoclax in combination with hypomethylating agents in newly diagnosed and relapsed acute myeloid leukemia. Haematologica\| PubMed ID: 39973368	2025
Cladribine Added to Idarubicin and Cytarabine as an Induction Regimen for Patients with De Novo Acute Myeloid Leukemia: A Multicenter, Randomized Phase III Trial. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 40008901	2025
Venetoclax and decitabine vs intensive chemotherapy as induction for young patients with newly diagnosed AML. Blood\| PubMed ID: 40009498	2025
[Efficacy and Safety of Venetoclax in Combination with Hypomethylating Agents for the Treatment of High-Risk Myelodysplastic Syndromes]. Zhongguo shi yan xue ye xue za zhi\| PubMed ID: 40017202	2025
Exploration of risk factors and characteristics of COVID-19 infection among patients with hematological malignancies in Suzhou, China: a retrospective study. Frontiers in oncology\| PubMed ID: 40061834	2024
Comparative Analysis of Treatment Outcomes and Prognostic Factors in Early T-Precursor Versus Non-ETP Acute Lymphoblastic Leukemia Following Allogeneic Hematopoietic Stem Cell Transplantatio... Transplantation proceedings\| PubMed ID: 40102132	2025
CAR T-Cell therapy in chronic myeloid leukemia patients with lymphoid blast crisis: A multicenter clinical analysis. Cancer letters\| PubMed ID: 40180115	2025
Efficacy of venetoclax combined with homoharringtonine and cytarabine for younger adults with newly diagnosed AML. Annals of hematology\| PubMed ID: 40180647	2025
Mendelian randomization analysis of blood metabolites and immune cell mediators in relation to GVHD and relapse. BMC medicine\| PubMed ID: 40189523	2025
Raffinose-metabolizing bacteria impair radiation-associated hematopoietic recovery the bile acid/FXR/NF-κB signaling pathway. Gut microbes\| PubMed ID: 40192235	2025
Clinical Outcomes of CD7 CAR-T Cell Therapy in Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Patients. Hematological oncology\| PubMed ID: 40227107	2025
The Anemia Risk Warning Model Based on a Noninvasive Method: Key Insights and Clarifications. JMIR medical informatics\| PubMed ID: 40262740	2025
CD19 CAR-T in relapsed t(8;21) AML: a single-center prospective phase II clinical trial. Journal of hematology & oncology\| PubMed ID: 40329358	2025
Hypermethylation of DNA impairs megakaryogenesis in delayed platelet recovery after allogeneic hematopoietic stem cell transplantation. Science advances\| PubMed ID: 40333970	2025
Correction: SPOP‑mediated ubiquitination and degradation of PDK1 suppresses AKT kinase activity and oncogenic functions. Molecular cancer\| PubMed ID: 40336083	2025
Learning-Based Classification of B- and T-Cell Lymphoma on Histopathological Images: A Multicenter Study. European journal of haematology\| PubMed ID: 40360162	2025
Real-world Efficacy and Safety of Flumatinib as the First-line Treatment in Patients With de novo Philadelphia-positive Acute Lymphoblastic Leukemia. Clinical lymphoma, myeloma & leukemia\| PubMed ID: 40374440	2025
Clinical value of metagenomic next-generation sequencing in screening oropharyngeal colonization in patients undergoing allogeneic hematopoietic stem cell transplantation: a prospective obse... Microbiology spectrum\| PubMed ID: 40422860	2025
Unveiling the role of lipid metabolism in haemorrhagic disorders: genetic insights and therapeutic perspectives. Thrombosis journal\| PubMed ID: 40450254	2025
A retrospective cohort study of chimeric antigen receptor T-Cell therapy in follicular lymphoma patients with or without histological transformation. Annals of hematology\| PubMed ID: 40455259	2025
mutation does not impact the prognosis of adult acute myeloid leukemia patients receiving a hematopoietic stem cell transplantation in first remission: similar outcome following matched sib... Haematologica\| PubMed ID: 40534491	2025
Elevated 5-HTR7 deteriorates dysregulated megakaryocytopoiesis in immune thrombocytopenic purpura via upregulating the PKA/Orai1/ERK1/2 pathway. Haematologica\| PubMed ID: 40534501	2025
Impact of ETV6 mutations on clinical outcomes in acute myeloid leukemia: a real-world retrospective cohort study. Annals of hematology\| PubMed ID: 40542832	2025
A model developed by machine learning and principal component analysis for predicting bronchiolitis obliterans syndrome after allogeneic HSCT in a Chinese population with hematologic maligna... Computers in biology and medicine\| PubMed ID: 40554974	2025
Landscapes of immunoglobulin heavy-chain gene repertoire and its cytogenetic abnormalities in Chinese patients with multiple myeloma. Scientific reports\| PubMed ID: 40594244	2025
Tandem CD19/CD22 CAR T-Cell Therapy as First-Line Treatment for Adult Patients With High-Risk Philadelphia Chromosome Negative B-Cell Acute Lymphoblastic Leukemia. American journal of hematology\| PubMed ID: 40616425	2025
Redefining multiple myeloma treatment: Advances, challenges, and future directions in immunotherapy. Chinese medical journal\| PubMed ID: 40784898	2025
KLF4 overexpression protects against complement-mediated endothelial injury in transplant-associated thrombotic microangiopathy. Haematologica\| PubMed ID: 40820810	2025
Autologous stem cell transplantation in NK/T-cell lymphoma: Prognostic impact of EBV-DNA in a multinational cohort-A study by the EBMT Lymphoma Working Party. HemaSphere\| PubMed ID: 40823316	2025
Poor prognosis of newly diagnosed multiple myeloma patients with 1p32.3 deletion in single monoallelic deletion and/or in main clone. British journal of haematology\| PubMed ID: 40824203	2025
Haploidentical Hematopoietic Cell Transplantation Combined with Umbilical Cord Blood Versus Haploidentical Hematopoietic Cell Transplantation in T-Cell Acute Lymphoblastic Leukemia Patients:... Transplantation and cellular therapy\| PubMed ID: 40829690	2025
Effective Management of Carbapenem-Resistant Enterobacterales Bloodstream Infection with Organ Dissemination in Prolonged Severe Agranulocytosis Patients with Hematological Malignancy Throug... Infectious diseases and therapy\| PubMed ID: 40877563	2025
Colistimethate sodium is efficacious and safe for the management of sepsis in hematological diseases patients: a retrospective study in China. Frontiers in cellular and infection microbiology\| PubMed ID: 40880630	2025
Effect of sorafenib on prognosis in patients with low-allelic-ratio FLT3-ITD acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation. Leukemia research\| PubMed ID: 40897098	2025
China Expert consensus on the application of metagenomic next-generation sequencing for the etiological diagnosis of infections in hematological disorders (2024). Blood science (Baltimore, Md.)\| PubMed ID: 40901069	2025
Similar Outcome With Haploidentical, Matched Sibling, or Matched Unrelated Donor Hematopoietic Cell Transplantation for Adult Patients With Adverse-Risk TP53-Mutated Acute Myeloid Leukemia i... American journal of hematology\| PubMed ID: 40927841	2025
Haploidentical versus matched unrelated donor hematopoietic cell transplantation for adult patients with refractory/relapsed acute lymphoblastic leukemia: a study from the Global Committee a... Bone marrow transplantation\| PubMed ID: 40954244	2025
Incidence, mortality, and survival associated with acute leukaemia subtypes by age group in China: a population-based cancer registry analysis and cohort study. The Lancet. Haematology\| PubMed ID: 41062205	2025
Phase II study of dual epigenetic targeting with chidamide and azacitidine in patients with high-risk acute myeloid leukemia after allo-HSCT. Clinical epigenetics\| PubMed ID: 41084078	2025
HLF gene is a poor prognostic factor in acute myeloid leukemia patients with FLT3-ITD/NPM1 mutations undergoing hematopoietic transplantation. PloS one\| PubMed ID: 41086161	2025
IL-6 knockdown anti-CD19 CAR-T cells (ssCART-19) for patients with relapsed or refractory acute lymphoblastic leukemia: phase 1 trial. Blood cancer journal\| PubMed ID: 41145445	2025
Expansion of peripheral helper T cells in the peripheral blood of patients with chronic graft-versus-host disease. Annals of hematology\| PubMed ID: 41177827	2025
Propensity Score-Matched Analysis Supports the Survival Benefits of Combination Chimeric Antigen Receptor T-Cell Therapy with Autologous Transplantation in Relapsed or Refractory Diffuse Lar... Transplantation and cellular therapy\| PubMed ID: 41197959	2025
A phase 2 trial of a "sandwich" strategy: Sequential CD22/CD19 chimeric antigen receptor T-cells therapy combined with autologous hematopoietic stem cell transplantation in patients with Phi... Cancer\| PubMed ID: 41199560	2025
Sustained remission with PD-1 and BTK inhibitors maintenance after chimeric antigen receptor T-cell therapy in CNS lymphoma. Cancer immunology, immunotherapy : CII\| PubMed ID: 41222665	2025
The interleukin-6 connection: Understanding cytomegalovirus reactivation following CAR-T-cell therapy. British journal of haematology\| PubMed ID: 41224498	2025
Haploidentical donor . human leukocyte antigen-matched donor hematopoietic cell transplantation for elderly patients with hematologic malignancies: Inferior non-relapse mortality but compara... Chinese journal of cancer research = Chung-kuo yen cheng yen chiu\| PubMed ID: 41229985	2025
Ruxolitinib as second-line therapy for bronchiolitis obliterans syndrome after hematopoietic cell transplantation: a retrospective multicenter study. Annals of hematology\| PubMed ID: 41266898	2025
A novel regulatory circuit of ATG4B and SESN3 promotes T cell leukemogenesis. Journal of experimental & clinical cancer research : CR\| PubMed ID: 41275290	2025
Integrative clinical and molecular characterization of an acute promyelocytic leukemia-like subgroup with high early death risk in newly diagnosed acute myeloid leukemia: a multicenter study... Haematologica\| PubMed ID: 41307138	2025
Venetoclax plus azacitidine in relapsed or refractory T-cell acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 trial. The Lancet. Haematology\| PubMed ID: 41338863	2025